{"id":26338,"date":"2016-05-25T11:31:06","date_gmt":"2016-05-25T09:31:06","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=26338"},"modified":"2016-06-13T13:10:17","modified_gmt":"2016-06-13T11:10:17","slug":"snami-adesso-anche-il-farmaco-di-stato","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/snami-adesso-anche-il-farmaco-di-stato\/","title":{"rendered":"SNAMI. Now also the state drug!"},"content":{"rendered":"

Angelo Testa: \u201cAnother madness that tramples the rule of law to be able to be treated. In fact, a blackmail to doctors and patients to use a "similar drug" that could have a different active ingredient"<\/em><\/p>\n

SNAMI - Press release 24 May 2016<\/span><\/a><\/p>\n

\"\"<\/p>\n

MEDICINAL PRODUCTS WITH THERAPEUTIC EQUIVALENCE<\/h4>\n

\"\"Rome 24 May 2016-Comment by the independent trade union on the cuts on a large number of medicines that would become payment for the sick, "Unless" says Angelo Testa, national president of Snami "the patients do not want to change therapy with a "similar drug \u201d. All, of course, for a matter of immediate cuts, the all-Italian path of the "hit and run" of today's savings, which does not take into account the costs of tomorrow, especially in terms of public health.<\/p>\n

There is an AIFA "determination", the "458" of last March 31 on the theme "Therapeutic equivalence between medicines containing different active ingredients", which makes us understand where we want to end up. The hypertensive patient who for years has been able to control his blood pressure with a given drug will henceforth have to pay for it or else he will have to accept, because he cannot afford it, the "state" drug which perhaps has a different active principle, with the aggravating factor that the following year the same could happen, therefore having to change again and consequently "having to discard" the medicine taken to replace the\"effetto-nocebo-farmaci\"receding. Again not with the same active ingredient.<\/p>\n

Total madness" denounces the leader of Snami "to be added to the telenovela of the decree cutting exams and to a set of idiocies that would like to prevent Doctors from carrying out their profession and citizens from being able to be treated"<\/p>\n

Snami Press Office<\/p>\n

Related news: Indecent Italy: between unjustified millionaire prizes and cuts in drug spending. Press release Fedaiisf<\/a><\/span><\/p>\n

Therapeutic equivalence, Garattini: Aifa is going in the right direction. Possible revolution<\/span><\/a><\/p>\n

Fimmg on procurement tenders for drugs with 'therapeutic equivalence'<\/a><\/span><\/p>\n

Determines AIFA 458\/2016<\/a><\/span><\/p>\n

Scaccabarozzi (Farmindustria) on the proposal of the governors: \u00abFrom the Regions only an old expired recipe\u00bb<\/a><\/span>\u00a0Thrust against therapeutic equivalence<\/p>\n

Healthcare, the reimbursement of 1,500 drugs at risk. "Sick people will have to pay or be treated with different active ingredients"<\/a><\/span><\/p>\n

Pharmaceutical governance. Yes to price\/volume and innovation. Doubts about double territorial ceiling and competition measures. The proposals of the Regions scrutinized by the Table of Palazzo Chigi<\/span><\/a><\/p>\n

Avastin-Lucentis case: they take away our essential drugs but leave us with Lucentis<\/span><\/a><\/p>\n

NHS crisis, the recipe can no longer be private healthcare<\/span><\/a><\/p>\n

 <\/p>","protected":false},"excerpt":{"rendered":"

Angelo Testa: “Ennesima follia che calpesta lo stato di diritto a potersi curare. Di fatto un ricatto a Medici e pazienti ad utilizzare un \u201c farmaco similare \u201d che potrebbe avere un principio attivo differente” SNAMI – Comunicato 24 maggio 2016 MEDICINALI AD EQUIVALENZA TERAPEUTICA Roma 24 Maggio 2016-Commento del sindacato autonomo ai tagli su …<\/p>","protected":false},"author":4,"featured_media":26340,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[26,79],"class_list":["post-26338","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-primo-piano","tag-spesa-farmaceutica","tag-ssn"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/26338","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=26338"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/26338\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/26340"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=26338"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=26338"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=26338"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}